SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. – Trademark Portfolio
Entity Type: 03
SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SOLIDFARMA SOLUCIONES EN LIDERAZGO FARMACÉUTICO. The owner is based in Ciudad de México.
ADOLFO L. MATEOS N.E.3395 N. I. Flr2,204
Ciudad de México 14120 , MX
Showing of trademarks Trademarks
Trademark Classifications
SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. have?
SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. file in?
SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.
What are SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V.'s most well-known trademarks?
SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V.'s registered trademark portfolio includes well-known marks such as SOLIDFARMA SOLUCIONES EN LIDERAZGO FARMACÉUTICO. These are among 1 currently registered trademark in the portfolio.
What is SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V.'s trademark registration success rate?
SOLUCIONES EN LIDERAZGO FARMACEUTICO, S.A. DE C.V. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.